203 related articles for article (PubMed ID: 3914748)
21. Improved lectin agglutination method for T-cell depletion of HLA-mismatched bone marrow grafts in children.
Schreiner T; Wiesneth M; Slaper-Cortenbach I; Maccari B; Erne E; Bischof C; Müller S; Friedrich W; Kubanek B
Transfus Sci; 1996 Dec; 17(4):637-42. PubMed ID: 10168564
[TBL] [Abstract][Full Text] [Related]
22. [T cell depletion for allogeneic bone marrow transplantation].
Morishima Y
Nihon Rinsho; 1990 Sep; 48(9):1971-6. PubMed ID: 2232199
[No Abstract] [Full Text] [Related]
23. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
25. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
Pollack MS; Kirkpatrick D; Kapoor N; Dupont B; O'Reilly RJ
N Engl J Med; 1982 Sep; 307(11):662-6. PubMed ID: 7050708
[No Abstract] [Full Text] [Related]
26. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
[No Abstract] [Full Text] [Related]
27. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
28. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
[No Abstract] [Full Text] [Related]
29. [Bone marrow transplantation and immunologic reconstitution].
Piazzon I; Dosne Pasqualini C
Medicina (B Aires); 1981; 41(2):233-43. PubMed ID: 7024717
[No Abstract] [Full Text] [Related]
30. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
31. [Bone marrow transplantation in childhood. Possibilities and risks].
Friedrich W; Ebell W
Monatsschr Kinderheilkd; 1987 May; 135(5):238-44. PubMed ID: 3302683
[TBL] [Abstract][Full Text] [Related]
32. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
33. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
34. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
35. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
[No Abstract] [Full Text] [Related]
36. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
37. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
38. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
39. Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells.
van Els C; Bakker A; van Rood J; Goulmy E
Transplant Proc; 1991 Feb; 23(1 Pt 1):429-30. PubMed ID: 1990577
[No Abstract] [Full Text] [Related]
40. A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.
O'Reilly RJ; Kirkpatrick D; Kapoor N; Collins N; Brochstein J; Kernan N; Flomenberg N; Pollack M; Dupont B; Lopez C
Prog Clin Biol Res; 1985; 193():327-42. PubMed ID: 3911216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
